Brief: Amniotics Q2 Operating Result (EBITDA) Loss Widens To SEK 17.2 Mln
Aug 27 (Reuters) - Amniotics AB (publ) AMNI.ST :
* INTERIM REPORT, 2ND QUARTER 2021
* Q2 OPERATING RESULT (EBITDA): SEK -17,238 (-4,859)
THOUSAND.
* Q2 RESULT FOR PERIOD: SEK -17,670 (5,260) THOUSAND.
Source text for Eikon: ID:nMFNc1mG7y
Further company coverage: AMNI.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Amniotics AB (publ)
See all newsBrief: Swedish Companies Registration Office Authorises Magle Group, Amniotics Merger Plan
Brief: Amniotics H1 Net Revenue SEK 2.5 Million
Brief: Amniotics Gets Conditional Approval To Delist From Nasdaq First North Growth Market
Brief: Amniotics To Delist From Nasdaq First North Growth Market Upon Magle Group Merger Completion
Brief: Magle Chemoswed, Amniotics Adopt Merger Plan